NI Reports Record Quarterly Revenue

This news release discloses the company’s EBITDA for the three-month and 12-month periods ending Dec. 31, 2020 and 2019. The company believes that including the EBITDA results assists investors in assessing the company’s operational performance relative to its competitors. A reconciliation of EBITDA to GAAP net income is included with this news release.

Forward-Looking Statements

This release contains “forward-looking statements” including statements regarding as we expand our systems and software offerings, we may see larger differences between bookings and revenue on a quarterly basis; the areas where we have focused showed strength and momentum increased throughout the year; I believe we enter 2021 in a position of strength and poised to accelerate growth and deliver increased value to all our stakeholders; I believe our strong close to 2020 is proof in our ability to adapt quickly to the global pandemic; we remain committed to our 2023 financial model; in order to accelerate growth, we will continue to align investments to our higher growth opportunities within our four strategic pillars; I believe our strong balance sheet gives us the opportunity to capitalize on inorganic investments to meet our growth targets faster and deliver shareholder returns; expecting Q1 revenue to be in the range of $324 million to $354 million; expecting Q1 non-GAAP revenue to be in the range of $325 million to $355 million; expecting that GAAP diluted EPS will be in the range of $(0.05) to $0.09 for Q1, with non-GAAP diluted EPS expected to be in the range of $0.24 to $0.38; and estimating its non-GAAP effective tax rate to be approximately 17 percent to 18 percent for 2021. These statements are subject to a number of risks and uncertainties, including risks and uncertainties related to the COVID-19 virus and further economic and market disruptions resulting from COVID-19; further adverse changes or fluctuations in the global economy; further adverse fluctuations in our industry, foreign exchange fluctuations, changes in the current global trade regulatory environment; fluctuations in customer demands and markets; fluctuations in demand for our products including orders from our large customers; component shortages; delays in the release of new products; our ability to effectively manage our operating expenses; manufacturing inefficiencies and the level of capacity utilization; the impact of any recent or future acquisitions or divestitures by NI (including the ability to successfully operate or integrate the acquired company’s business into NI, the ability to retain and integrate the acquired company’s employees into NI, and the ability to realize the expected benefits of the acquisition); our ability to achieve the benefits of employee restructuring plans and possible changes in the size and timing of the related charges; cyber-attacks; expense overruns; and adverse effects of price changes or effective tax rates. Actual results may differ materially from the expected results. The company directs readers to its Form 10-K for the year ended Dec. 31, 2019, its Form 10-Q for the quarter ended Sept. 30, 2020 and the other documents it files with the SEC for other risks associated with the company’s future performance. These documents contain and identify important factors that could cause our actual results to differ materially from those contained in our forward-looking statements.

All information in this release is as of the date above. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company’s expectations.

About NI

At NI, we bring together the people, ideas and technology so forward thinkers and creative problem solvers can take on humanity’s biggest challenges. From data and automation to research and validation, we provide the tailored, software-connected systems engineers and enterprises need to Engineer Ambitiously™ every day. (NATI-F)

National Instruments, NI and ni.com are trademarks of National Instruments. Other product and company names listed are trademarks or trade names of their respective companies.

 

National Instruments

Condensed Consolidated Balance Sheets

(in thousands)

 

December 31,

December 31,

 

2020

2019

 

(unaudited)

 

ASSETS

 

 

Current assets:

 

 

Cash and cash equivalents

$

260,232

 

$

194,616

 

Short-term investments

59,923

 

237,983

 

Accounts receivable, net

266,869

 

248,872

 

Inventories, net

194,012

 

200,410

 

Prepaid expenses and other current assets

68,470

 

65,477

 

Total current assets

849,506

 

947,358

 

Property and equipment, net

254,399

 

243,717

 

Goodwill

467,547

 

262,242

 

Intangible assets, net

172,719

 

84,083

 

Operating lease right-of-use assets

67,674

 

70,407

 

Other long-term assets

79,670

 

44,082

 

Total assets

1,891,515

 

1,651,889

 

 

 

 

LIABILITIES AND EQUITY

 

 

Current liabilities:

 

 

Accounts payable and accrued liabilities

51,124

 

52,192

 

Accrued compensation

87,068

 

47,732

 

Deferred revenue - current

132,151

 

131,445

 

Other lease liabilities - current

15,801

 

13,431

 

Other taxes payable

48,129

 

40,607

 

Debt - current

5,000

 

 

Other current liabilities

42,578

 

20,716

 

Total current liabilities

381,851

 

306,123

 

Deferred income taxes

25,287

 

14,065

 

Liability for uncertain tax positions

10,868

 

6,652

 

Income tax payable - non-current

61,623

 

69,151

 

Deferred revenue - long-term

36,335

 

33,480

 

Operating lease liabilities - non-current

35,854

 

40,650

 

Debt, non-current

92,036

 

 

Other long-term liabilities

22,789

 

5,418

 

Total liabilities

666,643

 

475,539

 

 

 

 

Stockholders' equity:

 

 

Preferred stock

 

 

Common stock

1,312

 

1,305

 

Additional paid-in capital

1,033,285

 

953,578

 

Retained earnings

211,101

 

242,537

 

Accumulated other comprehensive loss

(20,826)

 

(21,070)

 

Total stockholders' equity

1,224,872

 

1,176,350

 

Total liabilities and stockholders' equity

$

1,891,515

 

$

1,651,889

 

 

National Instruments

Condensed Consolidated Statements of Income

(in thousands, except per share data, unaudited)

 

 

 

 

 

 

Three Months Ended

 

Years Ended

 

December 31,

 

December 31,

 

2020

 

2019

 

2020

 

2019

 

 

 

 

 

 

Net sales:

 

 

 

 

 

Product

$

327,714

 

$

332,267

 

 

$

1,137,603

 

$

1,215,014

 

Software maintenance

40,124

 

35,201

 

 

149,068

 

138,201

 

Total net sales

367,838

 

367,468

 

 

1,286,671

 

1,353,215

 

 

 

 

 

 

 

Cost of sales:

 

 

 

 

 

Product

105,625

 

89,308

 

 

359,861

 

329,364

 

Software maintenance

3,571

 

1,827

 

 

11,260

 

7,527

 

Total cost of sales

109,196

 

91,135

 

 

371,121

 

336,891

 

 

 

 

 

 

 

Gross profit

258,642

 

276,333

 

 

915,550

 

1,016,324

 

 

70%

75%

 

71%

75%

Operating expenses:

 

 

 

 

 

Sales and marketing

134,570

 

121,052

 

 

465,509

 

473,392

 

Research and development

73,733

 

71,471

 

 

280,381

 

272,452

 

General and administrative

36,883

 

30,129

 

 

129,863

 

122,768

 

Total operating expenses

245,186

 

222,652

 

 

875,753

 

868,612

 

Gain on sale of business/asset

 

 

 

159,753

 

26,842

 

Operating income

13,456

 

53,681

 

 

199,550

 

174,554

 

 

 

 

 

 

 

Other income (expense)

1,797

 

611

 

 

(788)

 

5,990

 

 

 

 

 

 

 

Income before income taxes

15,253

 

54,292

 

 

198,762

 

180,544

 

 

 

 

 

 

 

Provision (Benefit) for income taxes

10,515

 

(4,304)

 

 

55,103

 

18,393

 

 

 

 

 

 

 

Net income

$

4,738

 

$

58,596

 

 

$

143,659

 

$

162,151

 

 

 

 

 

 

 

Basic earnings per share

$

0.04

 

$

0.45

 

 

$

1.10

 

$

1.23

 

Diluted earnings per share

$

0.04

 

$

0.45

 

 

$

1.09

 

$

1.22

 

 

 

 

 

 

 

Weighted average shares outstanding -

 

 

 

 

 

Basic

131,277

 

130,776

 

 

131,082

 

131,722

 

Diluted

131,732

 

131,432

 

 

131,799

 

132,734

 

 

 

 

 

 

 

Dividends declared per share

$

0.26

 

$

0.25

 

 

$

1.04

 

$

1.00

 

 

National Instruments

Condensed Consolidated Statements of Cash Flows

(in thousands)

 

Years Ended December 31,

 

2020

 

2019

 

(unaudited)

 

 

Cash flow from operating activities:

 

 

Net income

$

143,659

 

$

162,151

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

Depreciation and amortization

87,064

 

73,541

 

Stock-based compensation

58,376

 

51,438

 

Disposal gain on sale of business/asset

(159,753)

 

(26,842)

 

Deferred income taxes

7,089

 

(12,680)

 

Net change in operating assets and liabilities

44,332

 

(23,203)

 

Net cash provided by operating activities

180,767

 

224,405

 

 

 

 

Cash flow from investing activities:

 

 

Capital expenditures

(49,652)

 

(60,857)

 

Proceeds from sale of assets/business, net of cash divested

160,266

 

32,492

 

Capitalization of internally developed software

(4,054)

 

(9,065)

 

Additions to other intangibles

(1,441)

 

(1,209)

 

Acquisitions of equity-method investments

(9,761)

 

(13,670)

 

Acquisitions, net of cash received

(334,981)

 

 

Purchases of short-term investments

(206,330)

 

(185,267)

 

Sales and maturities of short-term investments

384,652

 

219,628

 

Net cash used by investing activities

(61,301)

 

(17,948)

 

 

 

 

Cash flow from financing activities:

 

 

Proceeds from term loan

170,000

 

 

Payments of term loan

(71,250)

 

 

Proceeds from revolving line of credit

20,000

 

 

Payments of revolving line of credit

(20,000)

 

 

Debt issuance costs

(1,893)

 

 

Proceeds from issuance of common stock

31,947

 

33,191

 

Repurchase of common stock

(48,713)

 

(171,316)

 

Dividends paid

(136,545)

 

(131,855)

 

Other

 

(837)

 

Net cash used by financing activities

(56,454)

 

(270,817)

 

 

 

 

Impact of changes in exchange rates on cash

2,604

 

(410)

 

 

 

 

Net change in cash and cash equivalents

65,616

 

(64,770)

 

Cash and cash equivalents at beginning of period

194,616

 

259,386

 

Cash and cash equivalents at end of period

$

260,232

 

$

194,616

 


« Previous Page 1 | 2 | 3 | 4  Next Page »



© 2024 Internet Business Systems, Inc.
670 Aberdeen Way, Milpitas, CA 95035
+1 (408) 882-6554 — Contact Us
ShareCG™ is a trademark of Internet Business Systems, Inc.

Report a Bug Report Abuse Make a Suggestion About Privacy Policy Contact Us User Agreement Advertise